Literature DB >> 25616722

Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.

Li Li Lin1, Wei Wang, ZhaoYang Hu, Li Wen Wang, Jing Chang, HanGuang Qian.   

Abstract

Primary hepatocellular carcinoma (HCC) is the most common form of liver cancer and is one of the most common malignancies worldwide. Tumor suppressor gene silencing through DNA methylation contributes to cancer formation. The ten-eleven translocations (TET) family of α-ketogluta-rate-dependent dioxygenases catalyzes the sequential oxidation of 5-methylcytosine to 5-hydroxymethyl-cytosine, 5-formylcytosine and 5-carboxylcytosine, leading to eventual DNA demethylation. MicroRNAs are an abundant class of 17-25 nucleotides small noncoding RNAs, identified as important regulators of many diverse biological processes. In this study, we showed that TET1 expression was obviously reduced in the majority of examined HCC tissues. And we further investigated the expression and functional involvement of TET1 in proliferation, migration and invasion and determined that TET1 may function as a tumor suppressor. miR-29b was proved to inhibit metastasis through the targeting of TET1, indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression. Thus, we elucidated the roles of feedback of miR-29-TET1 downregulation in HCC development and suggested a potential target in identification of the prognosis and application of cancer therapy for HCC patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25616722     DOI: 10.1007/s12032-014-0437-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  36 in total

1.  Dnmt3L and the establishment of maternal genomic imprints.

Authors:  D Bourc'his; G L Xu; C S Lin; B Bollman; T H Bestor
Journal:  Science       Date:  2001-11-22       Impact factor: 47.728

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 3.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

4.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

5.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

Authors:  Ramiro Garzon; Shujun Liu; Muller Fabbri; Zhongfa Liu; Catherine E A Heaphy; Elisa Callegari; Sebastian Schwind; Jiuxia Pang; Jianhua Yu; Natarajan Muthusamy; Violaine Havelange; Stefano Volinia; William Blum; Laura J Rush; Danilo Perrotti; Michael Andreeff; Clara D Bloomfield; John C Byrd; Kenneth Chan; Lai-Chu Wu; Carlo M Croce; Guido Marcucci
Journal:  Blood       Date:  2009-02-11       Impact factor: 22.113

Review 6.  Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.

Authors:  Augusto Villanueva; Sara Toffanin; Josep M Llovet
Journal:  Curr Opin Oncol       Date:  2008-07       Impact factor: 3.645

7.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Authors:  Laura Gramantieri; Manuela Ferracin; Francesca Fornari; Angelo Veronese; Silvia Sabbioni; Chang-Gong Liu; George A Calin; Catia Giovannini; Eros Ferrazzi; Gian Luca Grazi; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

8.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.

Authors:  Huating Wang; Ramiro Garzon; Hao Sun; Katherine J Ladner; Ravi Singh; Jason Dahlman; Alfred Cheng; Brett M Hall; Stephen J Qualman; Dawn S Chandler; Carlo M Croce; Denis C Guttridge
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

9.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes.

Authors:  Chiara Braconi; Nicola Valeri; Pierluigi Gasparini; Nianyuan Huang; Cristian Taccioli; Gerard Nuovo; Tetsuro Suzuki; Carlo Maria Croce; Tushar Patel
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

View more
  4 in total

Review 1.  Multiple Functions of Ten-eleven Translocation 1 during Tumorigenesis.

Authors:  Yi-Ping Tian; Yi-Min Zhu; Xiao-Hui Sun; Mao-De Lai
Journal:  Chin Med J (Engl)       Date:  2016-07-20       Impact factor: 2.628

Review 2.  Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.

Authors:  Penghui Wang; Yunmeng Yan; Wei Yu; Hongyi Zhang
Journal:  Cell Prolif       Date:  2019-04-29       Impact factor: 6.831

3.  Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.

Authors:  Yanfeng Liu; Jianping Song; Yu Liu; Zhipeng Zhou; Xianqiang Wang
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

Review 4.  The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.

Authors:  Eckhard Klieser; Christian Mayr; Tobias Kiesslich; Till Wissniowski; Pietro Di Fazio; Daniel Neureiter; Matthias Ocker
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.